No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract TOURMALINE-MM2 trial: Oral ixazomib, lenalidomide, and dexamethasone is a feasible and well-tolerated all-oral regimen in non-transplant, newly diagnosed multiple myeloma

byKathleen Lau

April 1, 2021

in StudyGraphics

#VisualAbstract TOURMALINE-MM2 trial: Oral ixazomib, lenalidomide, and dexamethasone is a feasible and well-tolerated all-oral regimen in non-transplant, newly diagnosed multiple myeloma

Fetal cardiovascular magnetic resonance may offer prenatal diagnostic information for indeterminate congenital heart defects

RelatedReports

A collection of symbolic items such as a microscope

Artificial Intelligence

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

September 30, 2026

Chronic Disease

Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma

September 28, 2026

Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026

Oncology

Daraxonrasib extends survival in metastatic pancreatic cancer

September 17, 2026

#VisualAbstract: Increased risk of cutaneous squamous cell carcinomas among patients diagnosed wtih actinic keratosis

#VisualAbstract: Late cranial neuropathy incidence may increase with time among oropharyngeal squamous cell carcinoma survivors

Shorter time to angioplasty may improve heart attack outcomes

ST-elevation myocardial infarctions in the absence of standard modifiable cardiovascular risk factors may have worse outcomes

Increased mortality among parents of children with major congenital anomalies

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract TOURMALINE-MM2 trial: Oral ixazomib, lenalidomide, and dexamethasone is a feasible and well-tolerated all-oral regimen in non-transplant, newly diagnosed multiple myeloma

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Fetal cardiovascular magnetic resonance may offer prenatal diagnostic information for indeterminate congenital heart defects

#VisualAbstract: Late cranial neuropathy incidence may increase with time among oropharyngeal squamous cell carcinoma survivors

RelatedReports

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Daraxonrasib extends survival in metastatic pancreatic cancer

#VisualAbstract: Late cranial neuropathy incidence may increase with time among oropharyngeal squamous cell carcinoma survivors

ST-elevation myocardial infarctions in the absence of standard modifiable cardiovascular risk factors may have worse outcomes

Increased mortality among parents of children with major congenital anomalies

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits

#VisualAbstract TOURMALINE-MM2 trial: Oral ixazomib, lenalidomide, and dexamethasone is a feasible and well-tolerated all-oral regimen in non-transplant, newly diagnosed multiple myeloma

RELATED REPORTS

Fetal cardiovascular magnetic resonance may offer prenatal diagnostic information for indeterminate congenital heart defects

#VisualAbstract: Late cranial neuropathy incidence may increase with time among oropharyngeal squamous cell carcinoma survivors

RelatedReports

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits